Related Experiment Video
Updated: Oct 11, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Stevens-Johnson Syndrome Caused by Enzalutamide: A Case Report and Literature Review
Min Deng1,2, Huirong Chai3, Meng Yang3
1College of life sciences and Biopharmaceuticals, Shenyang Pharmaceutical University, Shenyang, China.
Objective:
Enzalutamide is the most frequently prescribed compound for treating metastatic castration-resistant prostate cancer (mCRPC). Common adverse drug events of enzalutamide are febrile neutropenia, hot flashes, hypertension, and fatigue.
Methods:
We present a case of a patient with mCRPC who received enzalutamide and developed Stevens-Johnson syndrome (SJS). The culprit drug was confirmed using the Naranjo Adverse Drug Reaction Probability Scale. Clinical characteristics and management principles were analyzed in combination with literature reports.
Results:
SJS occurred within two weeks of enzalutamide therapy. Supportive care such as steroid treatment led to a complete resolution of skin lesions and improved clinical symptoms after three weeks.
Conclusion:
Most cutaneous adverse events occur early during enzalutamide therapy, and close observation should be given within two weeks of starting treatment.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
03:37Iatrogenic Injury Recapitulated: Electroexcision Technique for Urethral Stricture Modeling in Rats
Published on: October 11, 2024
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Urinary Tract Calculi III: Medical Management
Drugs for Treatment of Ulcerative Colitis in IBD
Acute Pyelonephritis II: Diagnostic Studies and Management